Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Norethandrolone

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Norethandrolone
Clinical data
Trade namesNilevar, Pronabol
Other namesNoretandrolone; CB-8022; 3-Ketoethylestrenol; Ethylestrenolone; 17α-Ethyl-19-nortestosterone; 17α-Ethylestr-4-en-17β-ol-3-one; 17α-Ethyl-19-norandrost-4-en-17β-ol-3-one; Ethylnandrolone; Ethylnortestosterone
AHFS/Drugs.comInternational Drug Names
Routes of
administration
By mouth
Drug classAndrogen;Anabolic steroid;Progestin;Progestogen
ATC code
Legal status
Legal status
Identifiers
  • (8R,9S,10R,13S,14S,17S)-17-ethyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
CAS Number
PubChemCID
ChemSpider
UNII
KEGG
CompTox Dashboard(EPA)
ECHA InfoCard100.000.140Edit this at Wikidata
Chemical and physical data
FormulaC20H30O2
Molar mass302.458 g·mol−1
3D model (JSmol)
  • O=C4\C=C3/[C@@H]([C@H]2CC[C@]1([C@@H](CC[C@@]1(O)CC)[C@@H]2CC3)C)CC4
  • InChI=1S/C20H30O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h12,15-18,22H,3-11H2,1-2H3/t15-,16+,17+,18-,19-,20-/m0/s1 checkY
  • Key:ZDHCJEIGTNNEMY-XGXHKTLJSA-N checkY
  (verify)

Norethandrolone, sold under the brand namesNilevar andPronabol among others, is anandrogen andanabolic steroid (AAS) medication which has been used to promotemusclegrowth and to treat severeburns,physical trauma, andaplastic anemia but has mostly been discontinued.[2][3][4] It is still available for use inFrance however.[3][4] It is takenby mouth.[3]

Side effects of norethandrolone includesymptoms ofmasculinization likeacne,increased hair growth,voice changes, and increasedsexual desire.[3] It can also causeestrogenic effects likefluid retention,breast tenderness, andbreast enlargement in men andliver damage.[3] The drug is asynthetic androgen and anabolic steroid and hence is anagonist of theandrogen receptor (AR), thebiological target of androgens liketestosterone anddihydrotestosterone (DHT).[3][5] It has stronganabolic effects relative to itsandrogenic effects.[3] The drug also has strongprogestogenic effects.[3]

Norethandrolone was discovered in 1953 and was introduced for medical use in 1956.[6][7] It was the first AAS with a favorable separation of anabolic and androgenic effect to be marketed.[7][8] The drug was mostly withdrawn in the 1980s due to concerns of liver damage.[9] In addition to its medical use, norethandrolone has been used toimprove physique and performance.[3] The drug is acontrolled substance in many countries and so non-medical use is generally illicit.[3]

Medical uses

[edit]

Norethandrolone has been used in the treatment ofmuscle wasting,[9] patients with severeburns, after severetrauma, and for certain forms ofaplastic anemia among other indications.[3]

Side effects

[edit]

Side effects of norethandrolone includevirilization among others.[3] It hasestrogenic effects and can causegynecomastia andfluid retention.[3] As with all17α-alkylated AAS, long-term use of norethandrolone in high doses may result inhepatotoxicity includingelevated liver enzymes andcirrhosis.[10]

Pharmacology

[edit]

Pharmacodynamics

[edit]
Androgenic vs. anabolic activity ratio
of androgens/anabolic steroids
MedicationRatioa
Testosterone~1:1
Androstanolone (DHT)~1:1
Methyltestosterone~1:1
Methandriol~1:1
Fluoxymesterone1:1–1:15
Metandienone1:1–1:8
Drostanolone1:3–1:4
Metenolone1:2–1:3
Oxymetholone1:2–1:9
Oxandrolone1:13–1:3
Stanozolol1:1–1:3
Nandrolone1:3–1:16
Ethylestrenol1:2–1:19
Norethandrolone1:1–1:2
Notes: In rodents.Footnotes:a = Ratio of androgenic to anabolic activity.Sources: See template.

Norethandrolone is anandrogen andanabolic steroid and hence is anagonist of theandrogen receptor, thebiological target of androgens liketestosterone anddihydrotestosterone.[3] It has a high ratio ofanabolic toandrogenic activity.[3] Analogously to the case ofnandrolone and5α-dihydronandrolone,5α-dihydronorethandrolone, the5α-reducedmetabolite of norethandrolone, shows diminishedaffinity for the androgen receptor relative to norethandrolone.[3][11] This is likely related to the high ratio of anabolic to androgenic activity observed with norethandrolone.[3][11] Norethandrolone has relatively highestrogenic activity via transformation byaromatase into the potentestrogenethylestradiol.[3] It also has strongprogestogenic activity.[3] The progestogenicpotency of norethandrolone is similar to that ofnorethisterone in terms ofendometrial changes in women.[12] In addition, norethandrolone ishepatotoxic.[3]

Relative affinities of nandrolone and related steroids at the androgen receptor
CompoundrAR(%)hAR(%)
Testosterone3838
5α-Dihydrotestosterone77100
Nandrolone7592
5α-Dihydronandrolone3550
EthylestrenolND2
NorethandroloneND22
5α-DihydronorethandroloneND14
Metribolone100110
Sources: See template.

Pharmacokinetics

[edit]

Thepharmacokinetics of norethandrolone have been reviewed.[13]

Chemistry

[edit]
See also:List of androgens/anabolic steroids andList of progestogens

Norethandrolone, also known as 17α-ethyl-19-nortestosterone or as 17α-ethylestr-4-en-17β-ol-3-one, is asyntheticestranesteroid and a17α-alkylatedderivative oftestosterone and19-nortestosterone (nandrolone).[2][3] It is closely related tonormethandrone (17α-methyl-19-nortestosterone) and toethylestrenol (3-deketo-17α-ethyl-19-nortestosterone).[2][3]

Synthesis

[edit]

Chemical syntheses of norethandrolone have been published.[13]

History

[edit]

Norethandrolone was synthesized atG. D. Searle & Company in 1953 and was originally studied as aprogestin, along withnorethisterone andnoretynodrel, but ultimately was not marketed as such.[6] In 1955, it was re-examined fortestosterone-like activity and was found to have similaranabolic activity to testosterone but only one-sixteenth theandrogenic potency.[6][9] Norethandrolone was introduced for medical use as an AAS in 1956 and was the first so-called "anabolic steroid", or AAS with a favorable separation of anabolic and androgenic effect, to be marketed.[7][8] It was followed bynormethandrone as a progestin in 1957 and by the more well-known AASnandrolone phenylpropionate in 1959.[14][8] Norethandrolone was introduced in theUnited States in the late 1950s under the brand name Nilevar but was discontinued in this country in the 1960s due to limited sales.[3] Although it was also introduced intoEurope and certain other markets,[3] it was withdrawn in many countries in the 1980s due to concerns ofcholestatic jaundice.[9] Today, the drug remains available only inFrance.[3][4]

Society and culture

[edit]

Generic names

[edit]

Norethandrolone is thegeneric name of the drug and itsINNTooltip International Nonproprietary Name andBANTooltip British Approved Name.[2][4] It has also been referred to asnoretandrolone,ethylnandrolone, andethylnortestosterone, as well as by its developmental code nameCB-8022.[2][4]

Brand names

[edit]

Norethandrolone is marketed under the brand names Nilevar and Pronabol.[2][3][4]

Availability

[edit]

Norethandrolone is available today only inFrance.[4][15]

Research

[edit]

Norethandrolone has been studied for use inmale hormonal contraception.[16][17][18]

References

[edit]
  1. ^Anvisa (2023-03-31)."RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese).Diário Oficial da União (published 2023-04-04).Archived from the original on 2023-08-03. Retrieved2023-08-15.
  2. ^abcdefJ. Elks (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 885–.ISBN 978-1-4757-2085-3.
  3. ^abcdefghijklmnopqrstuvwxyzWilliam Llewellyn (2011).Anabolics. Molecular Nutrition Llc. pp. 575–583.ISBN 978-0-9828280-1-4.
  4. ^abcdefg"List of Androgens and anabolic steroids".
  5. ^Kicman AT (2008)."Pharmacology of anabolic steroids".Br. J. Pharmacol.154 (3):502–21.doi:10.1038/bjp.2008.165.PMC 2439524.PMID 18500378.
  6. ^abcCharles D. Kochakian (6 December 2012).Anabolic-Androgenic Steroids. Springer Science & Business Media. pp. 380–.ISBN 978-3-642-66353-6.
  7. ^abcCamille Georges Wermuth (2 May 2011).The Practice of Medicinal Chemistry. Academic Press. pp. 34–.ISBN 978-0-08-056877-5.
  8. ^abcJames Edward Wright (1994).Altered States: The Use and Abuse of Anabolic Steroids. Masters Press. p. 33.ISBN 978-1-57028-013-9.
  9. ^abcdWalter Sneader (23 June 2005).Drug Discovery: A History. John Wiley & Sons. pp. 206–.ISBN 978-0-471-89979-2.
  10. ^Daniel Lednicer (20 June 2011).Steroid Chemistry at a Glance. John Wiley & Sons. pp. 67–.ISBN 978-1-119-95729-4.
  11. ^abBergink EW, Geelen JA, Turpijn EW (1985). "Metabolism and receptor binding of nandrolone and testosterone under in vitro and in vivo conditions".Acta Endocrinol Suppl (Copenh).271 (3_Suppla):31–7.doi:10.1530/acta.0.109S0031.PMID 3865479.
  12. ^Boschann HW (July 1958). "Observations of the role of progestational agents in human gynecologic disorders and pregnancy complications".Ann. N. Y. Acad. Sci.71 (5):727–52.Bibcode:1958NYASA..71..727B.doi:10.1111/j.1749-6632.1958.tb46803.x.PMID 13583829.
  13. ^abDie Gestagene. Springer-Verlag. 27 November 2013. pp. 13,282–283.ISBN 978-3-642-99941-3.
  14. ^United States. Patent Office (1957).Official Gazette of the United States Patent Office. U.S. Patent Office.
  15. ^"IBM Watson Health Products".
  16. ^Schearer SB, Alvarez-Sanchez F, Anselmo J, Brenner P, Coutinho E, Latham-Faundes A, et al. (1978)."Hormonal Contraception for Men".International Journal of Andrology.1 (s2b):680–712.doi:10.1111/j.1365-2605.1978.tb00517.x.ISSN 0105-6263.
  17. ^Neumann F, Diallo FA, Hasan SH, Schenck B, Traore I (1976)."The influence of pharmaceutical compounds on male fertility".Andrologia.8 (3):203–35.doi:10.1111/j.1439-0272.1976.tb02137.x.PMID 793446.S2CID 24859886.
  18. ^Brenner PF, Bernstein GS, Roy S, Jecht EW, Mishell DR (February 1975). "Administration of norethandrolone and testosterone as a contraceptive agent for men".Contraception.11 (2):193–207.doi:10.1016/0010-7824(75)90030-x.PMID 1112088.


Androgens
(incl.AASTooltip anabolic–androgenic steroid)
ARTooltip Androgen receptoragonists
Progonadotropins
Antiandrogens
ARTooltip Androgen receptorantagonists
Steroidogenesis
inhibitors
5α-Reductase
Others
Antigonadotropins
Others
Estrogens
ERTooltip Estrogen receptor agonists
Progonadotropins
Antiestrogens
ERTooltip Estrogen receptor antagonists
(incl.SERMsTooltip selective estrogen receptor modulators/SERDsTooltip selective estrogen receptor downregulators)
Aromatase inhibitors
Antigonadotropins
Others
Progestogens
(andprogestins)
PRTooltip Progesterone receptoragonists
Antiprogestogens
SPRMsTooltip Selective progesterone receptor modulators
PRTooltip Progesterone receptorantagonists
ARTooltip Androgen receptor
Agonists
SARMsTooltip Selective androgen receptor modulator
Antagonists
GPRC6A
Agonists
ERTooltip Estrogen receptor
Agonists
Mixed
(SERMsTooltip Selective estrogen receptor modulators)
Antagonists
GPERTooltip G protein-coupled estrogen receptor
Agonists
Antagonists
Unknown
PRTooltip Progesterone receptor
Agonists
Mixed
(SPRMsTooltip Selective progesterone receptor modulators)
Antagonists
mPRTooltip Membrane progesterone receptor
(PAQRTooltip Progestin and adipoQ receptor)
Agonists
Antagonists
Retrieved from "https://en.wikipedia.org/w/index.php?title=Norethandrolone&oldid=1303036229"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp